Literature DB >> 18190901

Facile synthesis and cytotoxicity of triterpenoid saponins bearing a unique disaccharide moiety: hederacolchiside A1 and its analogues.

Mao-Cai Yan1, Yang Liu, Wen-Xiang Lu, Hui Wang, Yu Sha, Mao-Sheng Cheng.   

Abstract

An improved synthetic approach toward hederacolchiside A1, an antitumor triterpenoid saponin bearing a unique disaccharide moiety, was established. This approach began from a partially protected intermediate and avoided tedious protection-deprotection manipulation. An abnormal ring conformation (1C4) of the center arabinose residue was found in the intermediate, which may account for the unusual regioselectivity between 3-OH and 4-OH of arabinose. Two analogues of hederacolchiside A1 were then facilely prepared by this approach and exhibited significant cytotoxicity in preliminary in vitro assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190901     DOI: 10.1016/j.carres.2007.12.014

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  4 in total

1.  The cephalostatins. 21. Synthesis of bis-steroidal pyrazine rhamnosides (1).

Authors:  George R Pettit; Ricardo F Mendonça; John C Knight; Robin K Pettit
Journal:  J Nat Prod       Date:  2011-09-07       Impact factor: 4.050

2.  Facile synthesis of the naturally cytotoxic triterpenoid saponin Patrinia-glycoside B-II and its conformer.

Authors:  Li Ren; Yong-Xiang Liu; Dan Lv; Mao-Cai Yan; Han Nie; Yang Liu; Mao-Sheng Cheng
Journal:  Molecules       Date:  2013-12-10       Impact factor: 4.411

3.  Synthesis and tumor cytotoxicity of novel amide derivatives of β-hederin.

Authors:  Yang Liu; Wen-Xiang Lu; Mao-Cai Yan; Yang Yu; Takashi Ikejima; Mao-Sheng Cheng
Journal:  Molecules       Date:  2010-11-03       Impact factor: 4.411

4.  Synthesis, Biological Evaluation, and Mode of Action of Pulsatilla Saponin D Derivatives as Promising Anticancer Agents.

Authors:  Yuanying Fang; Daoyong Hu; Huilan Li; Jianguo Hu; Yanhua Liu; Zhifeng Li; Guoliang Xu; Lanying Chen; Yi Jin; Shilin Yang; Zunhua Yang
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.